196 related articles for article (PubMed ID: 31961467)
1. Pharmacogenetics in Practice: Estimating the Clinical Actionability of Pharmacogenetic Testing in Perioperative and Ambulatory Settings.
Smith DM; Peshkin BN; Springfield TB; Brown RP; Hwang E; Kmiecik S; Shapiro R; Eldadah Z; Lundergan C; McAlduff J; Levin B; Swain SM
Clin Transl Sci; 2020 May; 13(3):618-627. PubMed ID: 31961467
[TBL] [Abstract][Full Text] [Related]
2. Primary Care Prescription Drug Use and Related Actionable Drug-Gene Interactions in the Danish Population.
Lunenburg CATC; Hauser AS; Ishtiak-Ahmed K; Gasse C
Clin Transl Sci; 2020 Jul; 13(4):798-806. PubMed ID: 32166845
[TBL] [Abstract][Full Text] [Related]
3. Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric Patients.
Ramsey LB; Ong HH; Schildcrout JS; Shi Y; Tang LA; Hicks JK; El Rouby N; Cavallari LH; Tuteja S; Aquilante CL; Beitelshees AL; Lemkin DL; Blake KV; Williams H; Cimino JJ; Davis BH; Limdi NA; Empey PE; Horvat CM; Kao DP; Lipori GP; Rosenman MB; Skaar TC; Teal E; Winterstein AG; Owusu Obeng A; Salyakina D; Gupta A; Gruber J; McCafferty-Fernandez J; Bishop JR; Rivers Z; Benner A; Tamraz B; Long-Boyle J; Peterson JF; Van Driest SL;
JAMA Netw Open; 2020 Dec; 3(12):e2029411. PubMed ID: 33315113
[TBL] [Abstract][Full Text] [Related]
4. Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines.
Pritchard D; Patel JN; Stephens LE; McLeod HL
Am J Health Syst Pharm; 2022 Jun; 79(12):993-1005. PubMed ID: 35230418
[TBL] [Abstract][Full Text] [Related]
5. Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing.
Dy GK; Nesline MK; Papanicolau-Sengos A; DePietro P; LeVea CM; Early A; Chen H; Grand'Maison A; Boland P; Ernstoff MS; Edge S; Akers S; Opyrchal M; Chatta G; Odunsi K; Pabla S; Conroy JM; Glenn ST; DeFedericis HT; Burgher B; Andreas J; Giamo V; Qin M; Wang Y; Kanehira K; Lenzo FL; Frederick P; Lele S; Galluzzi L; Kuvshinoff B; Morrison C
BMC Med Inform Decis Mak; 2019 Jan; 19(1):14. PubMed ID: 30658646
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group.
Bank PCD; Caudle KE; Swen JJ; Gammal RS; Whirl-Carrillo M; Klein TE; Relling MV; Guchelaar HJ
Clin Pharmacol Ther; 2018 Apr; 103(4):599-618. PubMed ID: 28994452
[TBL] [Abstract][Full Text] [Related]
7. [How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines].
Hafner S; Haubensak S; Paul T; Zolk O
Dtsch Med Wochenschr; 2016 Oct; 141(21):e183-e202. PubMed ID: 27750332
[No Abstract] [Full Text] [Related]
8. Evaluation of population-level pharmacogenetic actionability in Alabama.
Davis BH; Williams K; Absher D; Korf B; Limdi NA
Clin Transl Sci; 2021 Nov; 14(6):2327-2338. PubMed ID: 34121327
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomic potential in advanced cancer patients.
Nichols D; Arnold S; Weiss HL; Wu J; Durbin EB; Miller R; Kolesar J
Am J Health Syst Pharm; 2019 Mar; 76(7):415-423. PubMed ID: 31361818
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of clinical impact of pharmacogenomics knowledge involved in CPIC guidelines on Chinese pediatric patients.
Qin W; Du Z; Xiao J; Duan H; Shu Q; Li H
Pharmacogenomics; 2020 Feb; 21(3):209-219. PubMed ID: 31967514
[No Abstract] [Full Text] [Related]
11. Implementing a personalized medicine program in a community health system.
Dressler LG; Bell GC; Ruch KD; Retamal JD; Krug PB; Paulus RA
Pharmacogenomics; 2018 Nov; 19(17):1345-1356. PubMed ID: 30345883
[TBL] [Abstract][Full Text] [Related]
12. Characterizing Pharmacogenetic Testing Among Children's Hospitals.
Brown JT; Ramsey LB; Van Driest SL; Aka I; Colace SI
Clin Transl Sci; 2021 Mar; 14(2):692-701. PubMed ID: 33325650
[TBL] [Abstract][Full Text] [Related]
13. Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression.
Rothschild AJ; Parikh SV; Hain D; Law R; Thase ME; Dunlop BW; DeBattista C; Conway CR; Forester BP; Shelton RC; Macaluso M; Brown K; Lewis D; Gutin A; Jablonski MR; Greden JF
Psychiatry Res; 2021 Feb; 296():113649. PubMed ID: 33360967
[TBL] [Abstract][Full Text] [Related]
14. Challenges and lessons learned from clinical pharmacogenetic implementation of multiple gene-drug pairs across ambulatory care settings.
Cicali EJ; Weitzel KW; Elsey AR; Orlando FA; Vinson M; Mosley S; Smith DM; Davis R; Drum L; Estores D; Franciosi JP; Hagen MG; Jerkins GJ; Mercado ES; Nainaparampil J; Padron A; Rosenberg EI; Wright A; Schmidt SO; Mathews CA; Cavallari LH; Johnson JA
Genet Med; 2019 Oct; 21(10):2264-2274. PubMed ID: 30926959
[TBL] [Abstract][Full Text] [Related]
15. Disease-drug database for pharmacogenomic-based prescribing.
Hussain S; Kenigsberg BB; Danahey K; Lee YM; Galecki PM; Ratain MJ; O'Donnell PH
Clin Pharmacol Ther; 2016 Aug; 100(2):179-90. PubMed ID: 26940584
[TBL] [Abstract][Full Text] [Related]
16. Analyzing the clinical actionability of germline pharmacogenomic findings in oncology.
Wellmann R; Borden BA; Danahey K; Nanda R; Polite BN; Stadler WM; Ratain MJ; O'Donnell PH
Cancer; 2018 Jul; 124(14):3052-3065. PubMed ID: 29742281
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetic associations and evidence-based pharmacogenomics guidelines: supporting label and off-label use of drug-gene interaction data.
Kisor DF; Monte AA; Müller DJ
Pharmacogenomics; 2020 May; 21(7):427-430. PubMed ID: 32319356
[No Abstract] [Full Text] [Related]
18. Assessment of Physician Adherence to Guidelines for the Diagnosis and Treatment of Benign Paroxysmal Positional Vertigo in Ambulatory Care Settings.
Dunlap PM; Khoja SS; Whitney SL; Freburger JK
JAMA Otolaryngol Head Neck Surg; 2018 Sep; 144(9):845-846. PubMed ID: 30128474
[TBL] [Abstract][Full Text] [Related]
19. A retrospective analysis of actionable pharmacogenetic/genomic biomarker language in FDA labels.
Yamazaki S
Clin Transl Sci; 2021 Jul; 14(4):1412-1422. PubMed ID: 33742770
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of FDA Boxed Warning on Prescribing Patterns of Fluoroquinolones for Uncomplicated Urinary Tract Infections.
Cowart K; Worley M; Rouby NE; Sando K
Ann Pharmacother; 2019 Dec; 53(12):1192-1199. PubMed ID: 31319681
[No Abstract] [Full Text] [Related]
[Next] [New Search]
